SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-18-002841
Filing Date
2018-09-26
Accepted
2018-09-26 08:00:14
Documents
3
Period of Report
2018-09-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM-K rxi_8k.htm 8-K 17894
2 CONFERENCE PRESENTATION rxi_8k-ex9901.htm EX-99.1 8312
3 GRAPHIC image_001.jpg GRAPHIC 258325
  Complete submission text file 0001683168-18-002841.txt   383239
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 181086877
SIC: 2834 Pharmaceutical Preparations